Drugmaker Biogen boosts profit outlook on ‘momentum’ for new drugs
Biogen also beat Wall Street’s Q2 adjusted profit estimate, although its net income dropped.
Biogen also beat Wall Street’s Q2 adjusted profit estimate, although its net income dropped.
